Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BioIntellisense, Inc. announced that it has received $45 million in funding from a group of investors

07/28/2021 EDT

BioIntellisense, Inc. announced that it has received $45 million in its series B a round of funding led by new investor Chimera Investments LLC. on July 28, 2021. The transaction included participation from new investors 7wire Ventures, Pendrell Corporation, Fresenius Medical Care North America Holdings Limited Partnership, Mary Tolan, James Murren, Koninklijke Philips N.V. returning investors Tripletree Holdings, Llc, CU Healthcare Innovation Fund, L.P. a fund managed by University of Colorado School of Medicine, Endowment Arm and University Of Colorado Hospital Authority. The transaction was oversubscribed.


ę S&P Capital IQ 2021
All news about PHILIPS NV
09/24PHILIPS NV : Jefferies maintains a Buy rating
MD
09/24PHILIPS : ‘Als je jezelf blijft ontwikkelen en lekker in je vel zit, kun je de beste..
PU
09/22BIGMEDILYTICS : transforming healthcare in Europe with Big Data and AI
PU
09/21HOSPITAL AT HOME : the future of care is anywhere, anytime
PU
09/17PHILIPS : at UNGA76 – helping establish the resilient healthcare systems needed in a..
PU
09/16PHILIPS NV : JP Morgan from Sell to Neutral
MD
09/16PHILIPS : University Medical Center Utrecht opens new ‘CT-Street' to enhance and acc..
PU
09/15PHILIPS : Three ways the private sector can help build health system resilience
PU
09/10PHILIPS : Why measuring our social impact makes a difference
PU
09/10PHILIPS NV : Barclays remains its Buy rating
MD
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2021 17 621 M 20 581 M 20 581 M
Net income 2021 1 343 M 1 569 M 1 569 M
Net Debt 2021 3 991 M 4 661 M 4 661 M
P/E ratio 2021 28,5x
Yield 2021 2,35%
Capitalization 35 419 M 41 445 M 41 368 M
EV / Sales 2021 2,24x
EV / Sales 2022 2,10x
Nbr of Employees 77 084
Free-Float 99,4%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 38,81 €
Average target price 50,07 €
Spread / Average Target 29,0%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-11.36%41 445
THERMO FISHER SCIENTIFIC30.92%233 954
DANAHER CORPORATION46.08%225 592
INTUITIVE SURGICAL, INC.23.92%120 627
SIEMENS HEALTHINEERS AG38.49%76 354
EDWARDS LIFESCIENCES CORPORATION31.61%72 973